GlassScriptPhysician profile
Ashley Hubbard
NPI 1003565169
$5,055.19
in general payments reported to CMS, 2019-2025
22 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what 88% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $205 · 2023: $1,227 · 2024: $2,374 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301 · Travel and Lodging: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,301.34 |
| Travel and Lodging | $549.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,550.37 | 2022-2025 | Watchman Flx, Watchman Access System, Ekosonic |
| Merck Sharp & Dohme LLC | $494.57 | 2022-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $431.99 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $429.20 | 2023-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $402.75 | 2022-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $389.37 | 2022-2025 | |
| Novo Nordisk INC | $282.44 | 2024-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $189.14 | 2024-2025 | Farxiga, Wainua |
| Heartflow, INC. | $168.82 | 2023-2025 | Ffrct |
| Daiichi Sankyo INC. | $166.40 | 2023-2024 | Injectafer |
| Abiomed | $145.58 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.09 | 2023-2024 | Jardiance |
| Pfizer INC. | $56.05 | 2025 | |
| Amgen INC. | $48.08 | 2023-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $24.93 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $23.40 | 2024 | Zio Monitor, Zio Xt Patch |
| Lantheus Medical Imaging, INC. | $23.07 | 2024 | |
| Medtronic, INC. | $20.83 | 2025 | Symplicity G3 |
| Lexicon Pharmaceuticals, INC. | $20.82 | 2023 | Inpefa |
| Bridgebio Pharma, INC. | $20.02 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $19.08 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $14.19 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.